Omni Health Inc (OMHE)

[mattsinvestmentclub]

DR Karyemaitre Aliffe DD
https://www.researchgate.net/project/Clinical-Cannabis-Medicinal-Marijuana-Evidenced-based-Implementation-Strategies

The first, which we can share now, is development in the sphere of a cannabinoid-based drug-development. In collaboration with Dr. Karyemaitre Aliffe, MD, Omni Health is finalizing a regulatory path to commercialization of a breakthrough, proprietary compound agent with the potential to treat chronic pain.

ABOUT DOCTOR Aliffe
Dr. Aliffe is a forward-looking, Harvard University and Stanford University-trained, entrepreneurial physician-scientist executive with over 25 years of experience building corporate growth and profitability with strategic visionary leadership. His core competencies include practicable innovation enabling competitive expansion into lucrative niche markets while effectively harmonizing internal medical and therapeutic standards with regional and national regulatory guidelines. From the laboratory to the operating room, his specialty has always been translational biotherapeutics— evidence-based, biopharmaceutical, [b]phytomedicinal and medicinal nutraceutical development capturing health professional and consumer self-care markets across North America, Europe, Australia and Asia. An eloquent and effective multilingual communicator,

Dr. Aliffe is also fluent in science and marketing, medicine and wellness, medicinal botany and clinical pharmacology, internet media and professional-to-consumer networking.

dayum andrey is attracting smart people.

HARVARD- AND STANFORD-TRAINED, ENTREPRENEURIAL PHYSICIAN~SCIENTIST
Multilingual Biomedical Executive and Engaging Public Speaker with 25+ Years Strategic Visionary Leadership Leveraging Breakthrough Science into Novel Medicinal Agents and Biotechnologies.

"Linked in profile"
FOCUS~
https://www.linkedin.com/in/karyemaliffe/
Molecular & Clinical Pharmacognosy
? Clinical Cannabis / Medicinal Marijuana
? Immunomodulation and Anti-Carcinogenesis
? Clinical Trials of Complex Natural Product Medicinals
? Quantitative Assessment of Therapeutic & Psychotropic Effects
? Human Performance Enhancement/Impairment Products Assessment

Integrative Product Pipeline Development and Science-based Marketing Strategies
? Evidence-based Development of Effective, Non-toxic, Medicinal Agents
? Proprietary Practitioner Formulations & Protocol Development
? Health Professional, Self-Care and OTC Market Capture

Translational Medicine and Bioethics
? Compassionate Use and "n-of-1" Trials
? Clinical Cannabis / Medicinal Marijuana
? Psychoneuroimmunology and Longevity


? EXECUTIVE LEADERSHIP & BUSINESS DEVELOPMENT

? Conscientious Professional, Proficient in the Liaison of Sound Science and Successful Commerce, efficiently managing capital, intellectual and personnel resources to meet and exceed projected goals.

? Team-Oriented Executive with Successful Global Experience Building Growth and Profitability by advancing scientific leadership position and competitive expansion into global niche markets, effectively managing regulatory affairs in accord with regional and international guidelines.


? STRATEGIC INNOVATION, DISCOVERY & IMPLEMENTATION

? Visionary Thought Leader, Providing Practicable Concepts to Initiate and Advance Leading-Edge Sciences in accord with accomplishment of corporate objectives.

? Cross-functional Management Expertise, Creating High-Productivity, Cooperative Networking among biomedical, technical and regulatory personnel, and in interface with corporate partners, extramural contractors, fiscal managers and investors.


doctor involved in nectar
http://blog.mdelivers.com/miracle-is-an-understatement-a-conversation-with-original-nectar/

What makes Original Nectar Different.

These days we use super-critical CO2 extraction – a method which takes up three rooms-full of machinery & lab equipment at our facility. We invested in an Eden Labs Hi-Flo system – the bleeding edge in extraction technology manufactured by the worlds leader and Eden is led by the father of modern extraction, Dr. Fritz Chess. Our primary end-users are extremely sick children & adults, so naturally we pay strict attention to lab testing & cleanliness. Our formulations are developed by MD’s and research scientists – all of which are available to consult with the patient/parents. Our team consists of Dr. Judy Mikovits, Dr. Frank Ruscetti, Karyemaitre Aliffe MD, and Dr. Kang Hsu.